Our purpose is to help our clients navigate technology change in pursuit of human health and wellbeing.
d-wise is dedicated to improving the life science industry by transforming domain knowledge into results. Driven by a passion to improve wellbeing, d-wise designs, builds and implements clinical and transparency solutions and provides services to client teams in R&D IT, Biostatistics and Transparency.
In clinical trials, our life science consultants and technologists optimize systems, business processes and programming talent. The Clinical analytics solutions (SCEs) built in partnership with our clients provide performance and flexibility for pivotal trial and real-world data analysis. These solutions are designed to maintain validation requirements and can be deployed and managed in either the public or d-wise cloud.
With the vision to transform the life sciences landscape by allowing everyone open and flexible access to data, our transparency consultants and delivery teams lead Transparency Strategy and leverage Blur to provide high utility data & documents for sharing.
d-wise offers both products and services to biometric and transparency leaders, helping clients clearly understand the technology options available for interconnecting manual and disparate systems and processes. Designed to be tailored to meet individual client needs, our solutions follow best practices GxP principles to ensure efficiency, quality and compliance. The strategies, solutions and services planned, built and managed by d-wise provide clients a strong partner in clinical product development and sharing.
Rooted in extensive domain knowledge of SAS software, R, R&D cloud micro-services, clinical development, submission data standards such as CDISC, SDTM, AdaM, XPORT, d-wise Acceleration Strategy and Acceleration Services provide enterprise level IT solutions to life science clinical trial and data science teams, including:
In transparency our consultants and software engineers, provides Transparency Strategy, De-Identification Services and Blur software to anonymize clinical study data and clinical study reports (CSR) for high utility sharing required by regulatory authorities. In addition to anonyimzation services and software we provide sponsors:
Partnering with our domain experts and collaborative sponsors, d-wise technologists and engineers developed Accel a turnkey validated cloud environment for clinical trial biostatistics and continually build Aspire & Blur with collaborative partnerships.
Accelerating clinical trials requires an automated, validated, and scalable system. Our technology and clinical trial experts have created services and products that enable you to focus on the science and get to market faster, including our cloud-based SCE Accel and our Acceleration Strategies and Services.
d-wise transparency services and software empower sponsors to meet EMA Policy 0070 and Health Canada Public Release of Clinical Information.
Built in collaboration with industry sponsors, Blur is an anonymization software that measures re-identification risk and automates anonymization of both document and data through Natural Language Programming. Available as a SaaS or as an outsourced service, d-wise also provides transparency strategy, software, and resources to enable sharing that powers medical innovation.
d-wise is privileged to have served these and other prominent pharmaceutical companies.